Expression of Recombinant Human Soluble Type II Transforming Growth Factor-β Receptor inPichia pastorisandEscherichia coli:Two Powerful Systems to Express a Potent Inhibitor of Transforming Growth Factor-β

This publication has 26 references indexed in Scilit:

• In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-beta 1: age-related differences.
  Annals of the Rheumatic Diseases, 1994
• Mechanism of activation of the TGF-β receptor
  Nature, 1994
• Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.
  Journal of Clinical Investigation, 1994
• Local injection of TGF-β increases the strength of tibial fractures in the rat
  Acta Orthopaedica, 1994
• A major advance in the use of growth factors to enhance wound healing.
  Journal of Clinical Investigation, 1993
• Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease
  Nature, 1992
• Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure
  Journal of Clinical Immunology, 1992
• Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase
  Cell, 1992
• Control of scarring in adult wounds by neutralising antibody to transforming growth factor β
  The Lancet, 1992
• In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis.
  The Journal of cell biology, 1989